HOMOPIPERAZINE COMPOUNDS THAT INHIBIT RIBOSOMAL FRAMESHIFTING BY BINDING TO RNA PSEUDOKNOT STRUCTURE OF SARS CORONAVIRUS
申请人:PARK Hyun-Ju
公开号:US20080207597A1
公开(公告)日:2008-08-28
Provided is a homopiperazine compound for inhibiting ribosomal frameshifting by binding to an RNA pseudoknot structure of SARS coronavirus. Particularly, the present invention provides a pharmaceutical composition for inhibiting synthesis of protein induced by −1 frameshifting by binding to an RNA pseudoknot structure specifically existing in SARS coronavirus. The composition includes a therapeutically effective amount of homopiperazine compound of following chemical formula 1 or a pharmaceutically accepted salt thereof, and a pharmaceutically accepted carrier or excipient.
COMPOUNDS AND METHODS FOR MODULATING RNA FUNCTION
申请人:Arrakis Therapeutics, Inc.
公开号:US20220402883A1
公开(公告)日:2022-12-22
The present invention provides compounds, compositions thereof, and methods of using the same.
COMPOUNDS AND METHODS OF TREATING RNA-MEDIATED DISEASES
申请人:Arrakis Therapeutics, Inc.
公开号:US20220281860A1
公开(公告)日:2022-09-08
The present invention provides compounds, compositions thereof, and methods of using the same.